D-二聚体含量检测在不同类型胰腺炎诊断中的价值

doi:10.3969/j.issn.1673-8640.2020.03.015

摘要/Abstract

摘要：

目的探讨D-二聚体（DD）含量检测在不同类型胰腺炎诊断中的价值。方法选取急性胰腺炎患者60例,其中轻症胰腺炎患者40例（轻症组）、重症胰腺炎患者20例（重症组）,同时选取健康志愿者60名作为对照组,检测各组DD、凝血酶原时间（PT）、活化部分凝血酶原时间（APTT）、凝血酶时间（TT）。结果重症组入院时DD、PT、APTT、TT明显高于轻症组和对照组（P<0.05）;轻症组入院时DD、PT、APTT、TT明显高于对照组（P<0.05）;轻症组和重症组入院后3 d DD、PT、APTT、TT较入院时明显升高（P<0.05）,其中轻症组入院后7 d各指标有所降低（P<0.05）,而重症组持续升高（P<0.05）;重症组入院时、入院后3 d、入院后7 d DD、PT、APTT、TT明显高于轻症组（P<0.05）;入院时DD、PT、APTT、TT判断急性胰腺炎严重程度的受试者工作特征（ROC）曲线下面积分别为0.866、0.801、0.776和0.835（P<0.05）。结论 DD、PT、APTT、TT检测在急性胰腺炎早期诊断中有一定的应用价值,有助于评估患者病情。

关键词: D-二聚体, 凝血酶原时间, 活化部分凝血酶原时间, 凝血酶时间, 急性胰腺炎, 严重程度

Abstract:

Objective To investigate the diagnostic value of D-dimer（DD） level in different types of pancreatitis. MethodsTotally,60 patients with acute pancreatitis were enrolled,and there were 40 cases of mild pancreatitis（mild group） and 20 cases of severe pancreatitis（severe group）. A total of 60 healthy subjects were enrolled as control group. The levels of DD,prothrombin time（PT）,activated partial thromboplastin time（APTT） and thrombin time（TT） were determined. Results The DD,PT,APTT and TT in severe group at admission were higher than those in mild group and control group（P<0.05）. The DD,PT,APTT and TT in mild group at admission were higher than those in control group（P<0.05）. The levels of DD,PT,APTT and TT in mild and severe groups at 3 d after admission were higher than those at admission（P<0.05）,and those at 7 d after admission in mild group were decreased（P<0.05）,while those in severe group continued to increase（P<0.05）. In severe group,DD,PT,APTT and TT at admission and 3 d,7 d after admission were higher than those in mild group（P<0.05）. The areas under receiver operating characteristic（ROC） curves of DD,PT,APTT and TT at admission in judging the severity of acute pancreatitis were 0.866,0.801,0.776 and 0.835,respectively（P<0.05）. Conclusions DD,PT,APTT and TT determinations play roles in the early diagnosis of acute pancreatitis and the assessment of disease severity.

Key words: D-dimer, Prothrombin time, Activated partial thromboplastin time, Thrombin time, Acute pancreatitis, Severity

中图分类号:

R446.1

孟红兵, 曹兴建, 范玉萍, 顾水晶, 李娜. D-二聚体含量检测在不同类型胰腺炎诊断中的价值[J]. 检验医学, 2020, 35(3): 260-263.

MENG Hongbing, CAO Xingjian, FAN Yuping, GU Shuijing, LI Na. Diagnostic value of D-dimer level in different types of pancreatitis[J]. Laboratory Medicine, 2020, 35(3): 260-263.

图/表 5

参考文献 18

[1]	HE W H,ZHU Y,ZHU Y,et al.Comparison of multifactor scoring systems and single serum markers for the early prediction of the severity of acute pancreatitis[J]. J Gastroenterol Hepatol,2017,32(11):1895-1901.
[2]	HORIBE M,NISHIZAWA T,SUZUKI H,et al.Timing of oral refeeding in acute pancreatitis:a systematic review and meta-analysis[J]. United European Gastroenterol J,2016,4(6):725-732.
[3]	HUBER W,PHILLIP V,SCHMID R,et al.Acute pancreatitis:what is new?[J]. Dtsch Med Wochenschr,2017,142(7):525-529.
[4]	KHAMAYSI I,SINGH P,NASSER S,et al.The role of heparanase in the pathogenesis of acute pancreatitis:a potential therapeutic target[J]. Sci Rep,2017,7(1): 715.
[5]	PORTELLI M,JONES C D.Severe acute pancreatitis:pathogenesis,diagnosis and surgical management[J]. Hepatobiliary Pancreat Dis Int,2017,16(2):155-159.
[6]	SRINIVASAN G,VENKATAKRISHNAN L,SAMBANDAM S,et al.Current concepts in the management of acute pancreatitis[J]. J Family Med Prim Care,2016,5(4):752-758.
[7]	WANG D,BI Y W,JI J T,et al.Extracorporeal shock wave lithotripsy is safe and effective for pediatric patients with chronic pancreatitis[J]. Endoscopy,2017,49(5):447-455.
[8]	BERGER F Z,MANCILLA A C.Chronic pancreatitis: retrospective review of 121 cases[J]. Rev Med Chil,2016,144(12):1544-1552.
[9]	TILLOU J D,TATUM J A,JOLISSAINT J S,et al.Operative management of chronic pancreatitis:a review[J]. Am J Surg,2017,214(2):347-357.
[10]	NYRÉN S,NORDGREN ROGBERG A,VARGAS PARIS R,et al. Detection of pulmonary embolism using repeated MRI acquisitions without respiratory gating:a preliminary study[J]. Acta Radiol,2017,58(3):272-278.
[11]	LIU B H,SUN M X,ZHOU N,et al.Detection and study of plasma D-dimer change in patients with acute exacerbation of chronic obstructive pulmonary disease[J]. J Biol Regul Homeost Agents,2016,30(3):839-845.
[12]	SUN H,LI Y,ZHANG Z F,et al.Increase in myeloid-derived suppressor cells(MDSCs) associated with minimal residual disease(MRD) detection in adult acute myeloid leukemia[J]. Int J Hematol,2015,102(5):579-586.
[13]	NAZERIAN P,MORELLO F,VANNI S,et al.Combined use of aortic dissection detection risk score and D-dimer in the diagnostic workup of suspected acute aortic dissection[J]. Int J Cardiol,2014,175(1):78-82.
[14]	卢晨霞,施正君,王东兴. D-二聚体联合C反应蛋白监测在急性胰腺炎临床分型及严重程度评估中的意义[J]. 实用临床医药杂志,2013,17(5):118-119.
[15]	吴鹏,孙翼,孙竞,等. 纤维蛋白原和D-二聚体在急性胰腺炎分型中的早期预测价值[J]. 湖北医药学院学报,2011,30(1):32-34.
[16]	丁敏,肖忠,孙多成,等. D-二聚体在急性胰腺炎中的临床应用进展[J]. 医学综述,2017,23(1):30-33.
[17]	施琛. D-二聚体水平检测对急性胰腺炎的临床诊断价值[J]. 中外医学研究,2012,10(30):37-38.
[18]	徐妍,韩志君,沈兰凤,等. 血清D-二聚体、CA-199、CA-125、CA-724及CEA对鉴别胰腺癌和慢性胰腺炎的临床应用价值[J]. 中外医疗,2016,35(33):4-6.

组别	例数	性别		年龄/岁	发病到入院时间/h
组别	例数	男/例	女/例	年龄/岁	发病到入院时间/h
对照组	60	36	24	42.21±5.41
轻症组	40	25	15	41.50±5.22	2.12±0.58
重症组	20	14	6	42.06±5.30	2.10±0.60
统计值		0.64		1.023	0.124
P值		>0.05		>0.05	>0.05

组别	例数	性别		年龄/岁	发病到入院时间/h
组别	例数	男/例	女/例	年龄/岁	发病到入院时间/h
对照组	60	36	24	42.21±5.41
轻症组	40	25	15	41.50±5.22	2.12±0.58
重症组	20	14	6	42.06±5.30	2.10±0.60
统计值		0.64		1.023	0.124
P值		>0.05		>0.05	>0.05

组别	例数	DD/（mg/L）	PT/s	APTT/s	TT/s
轻症组	40	0.54±0.16^#	13.10±1.30^#	30.03±6.88^#	14.22±1.33^#
重症组	20	1.20±0.54^#*	16.50±2.25^#*	42.23±7.26^#*	16.70±1.24^#*
对照组	60	0.22±0.10	12.01±1.22	27.71±4.50	13.35±1.40
F值		6.845	7.106	8.225	6.905
P值		<0.05	<0.05	<0.05	<0.05

组别	例数	DD/（mg/L）	PT/s	APTT/s	TT/s
轻症组	40	0.54±0.16^#	13.10±1.30^#	30.03±6.88^#	14.22±1.33^#
重症组	20	1.20±0.54^#*	16.50±2.25^#*	42.23±7.26^#*	16.70±1.24^#*
对照组	60	0.22±0.10	12.01±1.22	27.71±4.50	13.35±1.40
F值		6.845	7.106	8.225	6.905
P值		<0.05	<0.05	<0.05	<0.05

组别	例数	DD/（mg/L）					PT/s
组别	例数	入院时	入院后3 d		入院后7 d		入院时	入院后3 d		入院后7 d
轻症组	40	0.54±0.16	0.76±0.21^*		0.65±0.23^*#		13.10±1.30	15.21±1.89^*		14.16±1.87^*#
重症组	20	1.20±0.54	1.70±0.42^*		1.91±0.31^*#		16.50±2.25	18.81±1.90^*		20.03±1.90^*#
组别	例数	APTT/s						TT/s
组别	例数	入院时		入院后3 d		入院后7 d		入院时	入院后3 d		入院后7 d
轻症组	40	30.03±6.88		34.41±7.10^*		29.81±8.22^#		14.22±1.33	15.91±1.20^*		14.44±1.21^#
重症组	20	42.23±7.26		49.03±6.55^*		53.33±7.60^*#		16.70±1.24	19.10±1.33^*		20.56±1.20^*#